Raymond James Financial’s Dillards DDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$592K Sell
1,121
-7
-0.6% -$4.04K ﹤0.01% 4391
2026
Q1
$645K Sell
1,128
-542
-32% -$338K ﹤0.01% 4175
2025
Q4
$1.01M Buy
1,670
+515
+45% +$324K ﹤0.01% 3763
2025
Q3
$710K Buy
1,155
+119
+11% +$61.5K ﹤0.01% 3899
2025
Q2
$433K Sell
1,036
-8,206
-89% -$3.06M ﹤0.01% 4093
2025
Q1
$3.31M Buy
9,242
+7,954
+618% +$3.42M ﹤0.01% 2620
2024
Q4
$556K Buy
+1,288
New +$528K ﹤0.01% 3844

Other funds holding DDS

Raymond James Financial's DDS Position: Q2 2026 in Review

Raymond James Financial reduced its Dillards (DDS) stake by 0.62% in Q2 2026, selling an estimated $4.04K and leaving 1,121 shares worth $592K. The position accounts for ﹤0.01% of the portfolio, ranked #4391.

Raymond James Financial first reported a position in DDS in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.31M in Q1 2025. 311 funds tracked by Wall St. Rank hold DDS as of Q2 2026.

  • Raymond James Financial held 1,121 shares of Dillards worth $592K as of Q2 2026.
  • Raymond James Financial sold 7 Dillards shares in Q2 2026, an estimated $4.04K.
  • Dillards made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4391 holding.
  • Raymond James Financial first reported a position in Dillards in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Dillards position peaked at $3.31M in Q1 2025.
  • 311 funds tracked by Wall St. Rank held Dillards as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.